Variables affecting in vivo performance of high-capacity adenovirus vectors

被引:44
|
作者
Schiedner, G
Hertel, S
Johnston, M
Biermann, V
Dries, V
Kochanek, S
机构
[1] Univ Cologne, Ctr Mol Med, ZMMK, D-50931 Cologne, Germany
[2] Univ Cologne, Inst Pathol, D-50931 Cologne, Germany
关键词
D O I
10.1128/JVI.76.4.1600-1609.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In high-capacity adenovirus (HC-Ad) vectors the size and/or composition of the vector genome influences vector stability during production and the expression profile following gene transfer. Typically, an HC-Ad vector will contain both a gene or an expression cassette and stuffer DNA that is required to balance the final vector genome to a size of between 27 and 36 kb. To gain an improved understanding of factors that may influence gene expression from HC-Ad vectors, we have generated a series of vectors that carry different combinations of human alpha-1 antitrypsin (hAAT) expression constructs and stuffer DNAs. Expression in vitro did not predict in vivo performance: all vectors expressed hAAT at similar levels when tested in cell culture. Hepatic expression was evaluated following in vivo gene transfer in C57BL/6J mice. hAAT levels obtained from genomic DNA were significantly higher than levels achieved with small cDNA expression cassettes. Expression was independent of the orientation and only marginally influenced by the location of the expression cassette within the vector genome. The use of lambda stuffer DNA resulted in low-level but stable expression for at least 3 months when higher doses were applied. A potential matrix attachment region element was identified within the hAAT gene and caused a 10-fold increase in expression when introduced in an HC-Ad vector genome carrying a phosphoglycerate kinase (pgk) hAAT cDNA construct. We also illustrate the influence of the promoter on anti-hAAT antibody formation in C57BL/6J mice: a human cytomegalovirus but not a pgk promoter resulted in an anti-hAAT antibody response. Thus, the overall design of HC-Ad vectors may significantly influence amounts and duration of gene expression at different levels.
引用
收藏
页码:1600 / 1609
页数:10
相关论文
共 50 条
  • [1] Approaches to Ameliorate the Amplification Process of High-Capacity Adenovirus Vectors
    Schiwon, Maren
    Brucher, Dominik
    Pluckthun, Andreas
    Ehrhardt, Anja
    MOLECULAR THERAPY, 2018, 26 (05) : 154 - 154
  • [2] High-capacity adenovirus vectors for stem and progenitor cell gene transfer
    Goncalves, Manuel A. F.
    Holkers, Maarten
    van Nierop, Gijsbert J.
    Knaaen-Shanzer, Shoshan
    de Vries, Antoine A. F.
    HUMAN GENE THERAPY, 2007, 18 (10) : 1042 - 1043
  • [3] High-capacity adenovirus/retrotransposon hybrid vectors for efficient and stable gene transfer
    Kubo, S
    Soifer, H
    Moran, JV
    Kazazian, HH
    Kasahara, N
    MOLECULAR THERAPY, 2004, 9 : S295 - S295
  • [4] High-capacity 'gutless' adenoviral vectors
    Kochanek, S
    Schiedner, G
    Volpers, C
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (05) : 454 - 463
  • [5] Targeting of high-capacity adenoviral vectors
    Biermann, V
    Volpers, C
    Hussmann, S
    Stock, A
    Kewes, H
    Schiedner, G
    Herrmann, A
    Kochanek, S
    HUMAN GENE THERAPY, 2001, 12 (14) : 1757 - 1769
  • [6] Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors
    Gonçalves, MAFV
    van der Velde, I
    Janssen, JM
    Maassen, BTH
    Heemskerk, EH
    Opstelten, DJE
    Knaän-Shanzer, S
    Valerio, D
    de Vries, AAF
    JOURNAL OF VIROLOGY, 2002, 76 (21) : 10734 - 10744
  • [7] Development of high-capacity gutless adenovirus vectors for gene transfer into human hematopoietic cells.
    Shayakhmetov, D
    Wang, HJ
    Leege, T
    Lieber, A
    BLOOD CELLS MOLECULES AND DISEASES, 2005, 34 (02) : 121 - 122
  • [8] Gene transfer with a high-capacity adenovirus vector.
    Gilgenkrantz, H
    M S-MEDECINE SCIENCES, 1998, 14 (05): : 669 - 670
  • [9] Retinal transduction profiles by high-capacity viral vectors
    Puppo, A.
    Cesi, G.
    Marrocco, E.
    Piccolo, P.
    Jacca, S.
    Shayakhmetov, D. M.
    Parks, R. J.
    Davidson, B. L.
    Colloca, S.
    Brunetti-Pierri, N.
    Ng, P.
    Donofrio, G.
    Auricchio, A.
    GENE THERAPY, 2014, 21 (10) : 855 - 865
  • [10] Development of high-capacity adenoviral vectors for gene therapy
    Kochanek, S
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 547 - 551